What is Emm?
Emm is a specialized biowearable technology company focused on revolutionizing menstrual health management. Under the leadership of CEO Jenny Button, the firm has developed a sophisticated wearable device that utilizes medical-grade silicone and advanced sensor technology to provide objective measurements of menstrual flow volume. Beyond simple tracking, the platform captures critical cycle metrics, including duration, frequency, and regularity, providing users with granular health insights. By prioritizing privacy and clinical-grade accuracy, Emm occupies a unique niche at the intersection of consumer electronics and reproductive health diagnostics, addressing a long-standing gap in personalized medical data for women.
How much funding has Emm raised?
Emm has raised a total of $10.1M across 2 funding rounds:
Other Financing Round
$1.1M
Seed
$9M
Other Financing Round (2022): $1.1M with participation from Innovate UK
Seed (2025): $9M led by Labcorp, Lunar Ventures, Blue Lion Global, and Alumni Ventures
Key Investors in Emm
Labcorp
Labcorp is a global laboratory services leader providing vital diagnostic information to healthcare providers, pharmaceutical companies, and patients to facilitate confident medical decision-making.
Lunar Ventures
Lunar Ventures is a prominent European deep-tech fund that supports technical founders with long-term capital and expertise in emerging infrastructure and scientific technologies.
Blue Lion Global
Blue Lion Global is an investment firm focused on early-stage startups across the US and Europe, specifically targeting founders solving significant societal challenges in finance, health, and energy.
What's next for Emm?
With this major strategic investment, Emm is poised to scale its operations and refine its sensor-based diagnostic capabilities. The company is expected to focus on expanding its market reach while continuing to invest in the research and development of its core hardware. As the femtech industry matures, Emm's ability to provide objective, longitudinal data will likely serve as a cornerstone for future partnerships with healthcare providers and clinical researchers. The strategic backing from industry-leading entities suggests a clear path toward integrating their wearable technology into broader digital health ecosystems, ultimately aiming to set a new standard for menstrual health monitoring and diagnostic precision.
See full Emm company page
